Magnemax tab. 500mg # 20
Package quantity, pcs:
twenty
fifty
Category
Vitamin and mineral complexes
Scope of the drug
Vitamins
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
twenty
Dosage form
Round flat-cylindrical tablets of white or almost white color with beveled and scored.
Structure
1 tablet contains:
active substance: magnesium orotate dihydrate 500 mg
excipients: lactose monohydrate, corn starch, microcrystalline cellulose, povidone K-30, croscarmellose sodium, colloidal silicon dioxide (aerosil), sodium cyclamate, talc, magnesium stearate.
pharmachologic effect
Magnesium preparation.
Magnesium is an essential trace element, it is involved in the implementation of more than 300 enzymatic reactions, regulation of cell permeability and neuromuscular excitability.
It is necessary for the provision of many energy processes, it is involved in the metabolism of proteins, fats, carbohydrates and nucleic acids.
Magnesium has a curariform effect on the endings of cholinergic neurons, with a decrease in acetylcholine release.
Magnesium and calcium interact in part synergistically in the body: however, when competitively inhibiting calcium, magnesium can also affect binding sites as a physiological calcium antagonist".
Pharmacokinetics
Approximately 35-40% of the dose taken is absorbed.
Hypomagnesemia stimulates the absorption of magnesium ions.
The presence of orotic acid salts helps to improve the absorption of magnesium.
Magnesium is excreted by the kidneys, excretion decreases with magnesium deficiency and increases with its excess.
Side effects
From the gastrointestinal tract: unstable stools and diarrhea, which usually go away on their own when the dose of the drug is reduced.
From the immune system: allergic reactions.
Selling features
Available without a prescription
Special conditions
The drug contains lactose monohydrate, so its use is not recommended for patients with hereditary galactosemia, glucose and galactose malabsorption syndrome and lactase deficiency.
Influence on the ability to drive vehicles and mechanisms The drug does not affect the ability to drive vehicles, mechanisms and engage in other activities that require increased concentration of attention and speed of psychomotor reactions.
Indications
Established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as irritability, minor sleep disturbances, gastrointestinal cramps, increased fatigue, muscle pain and spasms, tingling sensation in the muscles.
If after a month of treatment there is no decrease in these symptoms, continued treatment is impractical.
Contraindications
Hypersensitivity to the components of the drug, urolithiasis, renal dysfunction, predisposition to the formation of calcium-magnesium-ammonium-phosphate stones, liver cirrhosis with ascites.
Children under the age of 18.
The drug contains lactose, so it should not be used in patients with lactose intolerance, lactase deficiency or glucose-galactose malabsorption.
Application during pregnancy and during breastfeeding
It can be used during pregnancy only on the recommendation of a doctor.
Magnesium passes into breast milk.
Avoid using the drug during breastfeeding.
The use of the drug during pregnancy and lactation is possible if the potential benefit to the mother outweighs the potential risk to the fetus and child.
Drug interactions
With the simultaneous administration of magnesium-containing drugs with iron preparations, sodium fluoride and tetracyclines, the absorption of the latter may decrease.
In addition, aminoquinolines, quinidine, penicillamine should not be administered simultaneously with magnesium preparations.
Therefore, these drugs should be taken at intervals of 2-3 hours.
Oral contraceptives, diuretics, muscle relaxants, glucocorticosteroids, insulin, reduce the effect of the drug.
Magnesium should be used with caution if you are taking magnesium.
Name ENG
MAGNEMAX
Clinical and pharmacological group
Magnesium preparation
ATX code
Magnesium orotate
Dosage
500mg
Structure
1 tablet contains: active ingredient: magnesium orotate dihydrate 500 mg
excipients: lactose monohydrate, corn starch, microcrystalline cellulose, povidone K-30, croscarmellose sodium, colloidal silicon dioxide (aerosil), sodium cyclamate, talc, magnesium stearate.
Indications
Established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as: - increased fatigue
- increased irritability
- tingling sensation in the muscles.
- minor sleep disturbances
- gastrointestinal cramps
- pain and muscle spasms
If after a month of treatment there is no decrease in these symptoms, continued treatment is impractical.
INN / Active ingredient
Magnesium orotate
Contraindications
Hypersensitivity to drug components
- urolithiasis disease
- impaired renal function
- predisposition to the formation of calcium-magnesium-ammonium-phosphate stones
- cirrhosis of the liver with ascites
- children under 18 years of age.
The drug contains lactose, so it should not be used in patients with lactose intolerance, lactase deficiency or glucose-galactose malabsorption.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 4 years
Specifications
Category
Vitamin and mineral complexes
Scope of the drug
Vitamins
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
twenty
Minimum age from
18 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Obolenskoe FP
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Magnesium drug
Anatomical and therapeutic characteristics
A12CC09 Magnesium orotate
Dosage form
Pills
Dosage (volume) of the substance in the preparation
magnesium orotate dihydrate 500 mg
Expiration date in days
1095
Package weight, g
25
Mode of application
:
Inside, before meals, with a small amount of liquid.
< br> Prescribe 2 tablets 3 times a day for 7 days, then 1 tablet 2-3 times daily.
The duration of the course of treatment is 4 weeks.
Information on technical characteristics, delivery set, country of manufacture "